Yasuyuki Fujita

发表

Regenerative medicine legislation in Japan for fast provision of cell therapy products

A. Kawamoto, Yasuyuki Fujita, 2016, Clinical pharmacology and therapeutics.

Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair

R. Kuroda, Tomoyuki Matsumoto, T. Niikura, 2023, BMC Medicine.

Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial

T. Kawaguchi, H. Koga, K. Yamakado, 2024, Regenerative therapy.